He added, “[Dr. Nabel]’s vision to build on the hospital’s legacy of excellence in care, research and teaching will strengthen further a steadfast commitment to our patients, their families and all the communities that we serve.”
For Dr. Nabel, the appointment to Brigham and Women’s/Faulkner Hospitals was a homecoming of sorts. She undertook her internship and residency in internal medicine and a clinical and research fellowship in cardiovascular medicine at BWH and Harvard University after receiving her MD from Cornell Medical College. Dr. Nabel is a board-certified cardiologist.
She called the appointment “a tremendous opportunity to share a personal passion with world-class clinicians and scientists to link excellent patient care to internationally-respected research and then carry our collective wisdom forward to our students, the future leaders of medicine.”
During her career, Dr. Nabel has focused her energy on those future leaders, having served on the faculty at the University of Michigan as an assistant professor of medicine. She went on to become director of the cardiovascular research center, professor of internal medicine and cardiology and chief of the division of cardiology at the university.
While at the University of Michigan, Dr. Nabel became well-known for her research in vascular biology and molecular cardiology, as well as in gene transfer studies of the cardiovascular system. She currently serves as director of the National Heart, Lung and Blood Institute of the NIH, where she actively participates in community service programs and emphasizes community outreach for women and victims of heart disease.
Dr. Nabel is a nationally renowned scholar and has worked with the NIH Vascular Biology Lab to publish 250 publications. She has been honored with membership in the American Academy of Arts and Sciences, the Association of American Physicians council and the Institute of Medicine of the National Academy of Sciences council. She also serves on the editorial boards of the New England Journal of Medicine and Science Translational Medicine.
Read more about notable hospital leaders:
–Hospital Industry Leader to Know: Debbie May of Texas Institute of Surgery
–Hospital Industry Leader to Know: Dr. Peter Slavin, CEO of Massachusetts General Hospital
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.
